"Silent" corticotropinoma

Neuroendocrinology Letters

Volumn 29, Issue 3, 2008, Pages 347-350

  Pawlikowski, Marek ^a   Kunert Radek, Jolanta ^a   Radek, Maciej ^a  

^a MEDICAL UNIVERSITY OF LODZ   (Poland)

Author keywords

Cushing's disease; Immunohistochemistry; Pituitary adenomas; Silent corticotropinomas

Indexed keywords

BIOTIN; DIAMINOBENZIDINE; KI 67 ANTIGEN; PEROXIDASE; STREPTAVIDIN;

ACTH SECRETING ADENOMA; ANTIGEN EXPRESSION; ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; CUSHING DISEASE; FEMALE; HUMAN; HUMAN TISSUE; HYPERCORTISOLISM; HYPOPHYSIS ADENOMA; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; INCIDENCE; MAJOR CLINICAL STUDY; MALE; RECURRENCE RISK; TUMOR CELL;

EID: 48049103880     PISSN: 0172780X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Kovacs K The pathology of Cushing's disease J Steroid Biochem Molec Biol 1993; 45: 179-182.
2. Kojima Y, Suzuki S, Yamamura K, Ohhashi G, Yamamoto I Comparison of ACTH secretion in Cushing's adenoma and clinically silent corticotroph adenoma by cell immunoblot assay Endocr J 2002; 49: 285-292.
3. Iino K, Oki Y, Matsuhita F, Yamashita M, Hayashi c, Miura K, Nishizawa S, Nakamura H Immunohistochemical properties of silent corticotroph adenoma and Cushing 's disease Pituitary 2007; 10: 35-45.
4. Reincke M, Allolio B, Saeger W, Kaulen D, Winkelmann W A pituitary adenoma secreting high molecular weight adenocorticotrophin without evidence of Cushing's disease. J Clin Endocrinol Metab 1987; 65: 1296-1300.
5. Gibson S, Ray W, Crosby SR, Dorman TL, Jemmings AM, Bevan S, Davis JR, White A Impaired processing of proopiomelanocortin in corticotroph macroadenomas J Clin Endocrinol Metab 1996; 81: 497-502.
6. Tateno T, Izumiyama H, Doi M, Akashi T, Ohno K, Hirata Y Defective expression of prohormone convertase 1/3 in silent corticotroph adenoma Endocr J 2007; 54: 777-782.
7. Tateno T, Izumiyama H, Doi M, Yashimoto T, Shichiri M, Inoshita N, Oyama K, Yamada S, Hirata Y Differential gene expression in ACTH-secreting and non-functioning pituitary tumors Eur J Endocrinol 2007; 157: 717-724.
8. Bradley KJ, Wass JA, Turner HE Non-functioning pituitary adenomas with positive immunoreactivity for ACTH behave more aggressively that ACTH immunonegative tumours but not recur more frequently Clin Endocrinol 2003; 58: 59-64.
9. Pawlikowski M, Gruszka A, Kurnatowska I, Winczyk K, Kunert-Radek J, Radek A Proliferating cell nuclear antigen (PCNA) expression in pituitary adenomas: relationship to the endocrine phenotype of adenoma Folia Histochem Cytobiol 2006; 44: 37-41
10. Nelson DH, Sprumt GI, Mims RB Plasma ACTH determinations in 58 patients before and after adrenalectomy for Cushing syndrome J Clin Endocrinol 1966; 26: 722-728.
11. Kasperlik-Zaluska AA, Nielubowicz J, Wislawski J, Hartwig W Zaluska J, Jeske W, Migdalska B Nelson's syndrome: incidence and prognosis Clin Endocrinol 1983; 19: 693-698.
12. Assie G, Bahurel H, Coste J, Silvera S, Kujas M, Dugue MA, Karray F, Dousset B, Bertherat J, Legmann P, Bertagna X Corticotroph tumor progression after adrenalectomy in Cushing's Disease:A reappraisal of Nelson's syndrome J Clin Endocrinol Metab 2007; 92: 172-179.
13. Jin L, Riss D, Ruebel K, Kajita S, Scheithauer BW, Horvath E, Kovacs K, Lloyd RV Galectin-3 expression in functioning and silent ACTH-producing adenomas Endocr Pathol 2005; 16: 107-114.
14. Thodou E, Argyrakos T, Kontogeorgos G Galectin -3 as a marker distinguishing functioning from silent corticotroph adenomas Hormones 2007; 6: 227-232.
15. Dabelic S, Suphra S, Dumic J Galectin-3 in macrophage-like cells exposed to immunomodulatory drugs Biochem Biophys Acta 2006; 1760: 701-709.